Related Experiment Video
Updated: May 9, 2026

07:20
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Extra-low-frequency magnetic fields alter cancer cells through metabolic restriction
1InVitroPlus Laboratory, Department of Surgery, Royal Victoria Hospital , Montreal, QC , Canada and.
Electromagnetic Biology and Medicine
|August 7, 2013
Summary
Extra-low-frequency magnetic fields (ELF-MFs) cause chromosome changes in cancer cells by interfering with energy production. These effects, linked to water structure, may impact cancer, diabetes, and longevity.
Area of Science:
- Biophysics
- Cell Biology
- Environmental Health
Background:
- The biological mechanisms of extra-low-frequency (ELF) magnetic fields (MFs) remain poorly understood.
- A credible interaction mechanism between MFs and biological systems is needed.
Purpose of the Study:
- To investigate the impact of ELF-MFs on cancer cell karyotypes.
- To elucidate the cellular and molecular pathways affected by ELF-MF exposure.
Main Methods:
- Exposing five cancer cell lines to ELF-MFs ranging from 0.025 to 5 µT.
- Analyzing karyotype changes in exposed cells after 6 days.
- Investigating the roles of adenosine triphosphate synthase (ATPS) and adenosine monophosphate-activated protein kinase (AMPK) pathways.
Main Results:
- ELF-MF exposure induced chromosome loss (karyotype contractions, KCs) in all tested cancer cell lines.
- KCs were reversible upon cessation of MF exposure but could be re-induced.
- MF effects mimicked ATPS inhibition and were modulated by AMPK activators/inhibitors, suggesting MF interference with mitochondrial function.
Conclusions:
- ELF-MFs alter water structure, impeding proton flux in ATPS channels, leading to KCs.
- These findings suggest a novel mechanism for MF biological effects, with potential implications for cancer, diabetes, and aging.
- The study highlights the environmental relevance of MF exposure due to the critical roles of ATPS and AMPK in human physiology.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
